Purchases and Sales Made in Q3 2022 in Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS) during Q3 2022. The information is specifically focused on institutions that hold shares of Arcus Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-33.3K- 19.46% |
$774K - $1M
|
138K
$1.36M
|
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-35K- 21.11% |
$812K - $1.05M
|
131K
$1.29M
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-38.4K- 49.16% |
$892K - $1.15M
|
39.7K
$392K
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-43.7K- 37.62% |
$1.02M - $1.31M
|
72.5K
$715K
|
|
|
Nov 14, 2022
Q3 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-44.1K- 23.03% |
$1.02M - $1.33M
|
147K
$1.45M
|
|
|
Feb 14, 2023
Q3 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-44.1K- 23.03% |
$1.02M - $1.33M
|
147K
$1.45M
|
|
|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-46.5K- 67.0% |
$1.08M - $1.4M
|
22.9K
$226K
|
|
|
Nov 08, 2022
Q3 2022
|
Park Circle CO
|
SELL
|
- |
-60.1K- 93.91% |
$1.4M - $1.81M
|
3.9K
$38.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-74.3K- 21.79% |
$1.72M - $2.23M
|
267K
$2.63M
|
|
|
Nov 10, 2022
Q3 2022
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-84.8K- 27.18% |
$1.97M - $2.55M
|
227K
$2.24M
|
|
|
Nov 14, 2022
Q3 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-88.4K- 84.6% |
$2.05M - $2.66M
|
16.1K
$159K
|
|
|
Nov 14, 2022
Q3 2022
|
Alpha Crest Capital Management LLC
New York, NY |
SELL
|
- |
-90.7K- 71.86% |
$2.11M - $2.73M
|
35.5K
$351K
|
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-91.9K- 8.14% |
$2.13M - $2.76M
|
1.04M
$10.2M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-111K- 11.37% |
$2.57M - $3.33M
|
863K
$8.52M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-111K- 11.37% |
$2.57M - $3.33M
|
863K
$8.52M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-111K- 89.85% |
$2.58M - $3.34M
|
12.6K
$124K
|
|
|
Nov 14, 2022
Q3 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-142K- 94.13% |
$3.29M - $4.26M
|
8.84K
$87.2K
|
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-210K- 92.21% |
$4.89M - $6.33M
|
17.8K
$176K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-231K- 39.51% |
$5.36M - $6.94M
|
353K
$3.48M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-294K- 6.62% |
$6.82M - $8.83M
|
4.14M
$40.9M
|
|
|
Nov 14, 2022
Q3 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-423K- 22.12% |
$9.83M - $12.7M
|
1.49M
$14.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-1.24M- 31.4% |
$28.9M - $37.4M
|
2.72M
$26.8M
|